← Leaderboards
Emily Sara Stieren
University Of Texas Med Br Galveston
$145,971
Attributed
$145,971
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $32.4K · FY2007–11$50K$37.5K$25K$12.5K$0
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$145,971 · 1
By mechanism
F30$145,971 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Texas Med Br Galveston
Same institution · by research overlap
- Kathryn A. Cunningham$26,840,884
- Allan R. Brasier$76,022,342
- Jia Zhou$10,435,378
- Rovshan G Sadygov$2,813,855
- Jonathan Dean Hommel$4,897,281
Others in their field
Top investigators on “Age Related”
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$171,224,107
- Judith S. Currier · University Of California Los Angeles$158,191,468
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$139,923,639
- David R. Weir · University Of Michigan At Ann Arbor$130,944,444
- Joseph E Robertson · Oregon Health & Science University$127,007,244
Research focus
Age RelatedAffectAmino Acid SequenceAmino Acid SubstitutionAlzheimer&AposAmyloid Beta-Protein PrecursorAmyloid PeptideAmyloid Precursor Protein ProcessingApoptosisBinding (Molecular Function)AmyloidBrainCdna LibraryCell DeathCell FractionationCell LineCellsCessation Of LifeCo-ImmunoprecipitationsC-TerminalCycloheximideCytoplasmic TailCytoprotectionCytotoxic
Grant awards (5)
The Role of Ubiquilin in Alzheimer's Disease$32,397
F30 · FY2011 · AG · contact PI
The Role of Ubiquilin in Alzheimer's Disease$31,977
F30 · FY2010 · AG · contact PI
The Role of Ubiquilin in Alzheimer's Disease$27,335
F30 · FY2009 · AG · contact PI
The Role of Ubiquilin in Alzheimer's Disease$27,131
F30 · FY2008 · AG · contact PI
The Role of Ubiquilin in Alzheimer's Disease$27,131
F30 · FY2007 · AG · contact PI